Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

The Lancet Diabetes & Endocrinology in conversation with
19/07/2022 9 min
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Listen "Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma"

Descargar episodio

Episode Synopsis

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Read the full article:Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngiomaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

More episodes of the podcast The Lancet Diabetes & Endocrinology in conversation with

Roy Taylor on the causes of type 2 diabetes 20/08/2024
Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe on early pregnancy HbA1c as a screening test for gestational diabetes 28/06/2024
Márta Korbonits on mechanisms of ageing 24/02/2023
Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus 20/09/2022
Rossella Nappi on menopause as a turning point for women's health 23/05/2022
Louise Baur on the causes of child and adolescent obesity 21/04/2022
Margherita Pizzato on the global epidemiological landscape of thyroid cancer 22/03/2022
Angela Titmuss on T2D in First Nations young people in northern Australia 04/02/2022
Sanjay Basu on affordable T2D medicine in LMICs 16/11/2021
Philip Home on the centenary of insulin 15/09/2021
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA